Srivastava Deepak
SEC CIK 1868501 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TNYA | Tenaya Therapeutics, Inc. | Dir | 372.4K | $600.0K | — | 1 | 2022-11-21 | 2022-11-21 |
Most active insiders at TNYA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | COLUMN GROUP III-A, LP | 10% | — | $3.54M |
| 2 | TCG Opportunity III GP, LLC | 10% | — | $2.37M |
| 3 | Ali Faraz | CEO, Dir | — | $32.1K |
| 4 | Tingley Whittemore | Chief Medical Off | — | $14.9K |
| 5 | Higa Tomohiro | SVP, Fin | — | $5,216 |
Srivastava Deepak made no open-market trades at TNYA in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-12-09 | 2022-11-21 | TNYA | Tenaya Therapeutics, Inc. | Srivastava Deepak | Dir | P - Purchase | $2.60 | +230.8K | 372.4K | +163% | +$600.0K |
Purchase Sale Sale after option exercise All abbreviations